Abstract
Pharmaceutical companies have leveraged traditional portfolio management approaches for over 20 years. This has brought benefits in prioritization of projects and resources and the development of portfolio strategies and goals. However, the nature of drug development creates challenges to a pure implementation of these portfolio management approaches. This paper highlights these challenges and offers approaches to overcome the challenges.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Reference
Sharpe P, Keelin T (1998) How SmithKline Beecham makes better resource-allocation decisions. Harv Bus Rev 76(2):45–57
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Persinger, C. (2015). Challenges of Portfolio Management in Pharmaceutical Development. In: Antonijevic, Z. (eds) Optimization of Pharmaceutical R&D Programs and Portfolios. Springer, Cham. https://doi.org/10.1007/978-3-319-09075-7_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-09075-7_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-09074-0
Online ISBN: 978-3-319-09075-7
eBook Packages: Business and EconomicsBusiness and Management (R0)